Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

Clinical trial NCT07151378 · RECRUITING

Trial details

NCT number: NCT07151378
Sponsor: University Hospital Tuebingen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

PARKINSON DISEASE (Disorder)

Start date: 2025-10-27
Primary completion: 2030-09-22
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.